Enovix Co. (NASDAQ:ENVX) Shares Sold by P.A.W. Capital Corp

P.A.W. Capital Corp trimmed its holdings in shares of Enovix Co. (NASDAQ:ENVXFree Report) by 16.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 100,000 shares of the company’s stock after selling 20,000 shares during the period. Enovix makes up about 2.1% of P.A.W. Capital Corp’s portfolio, making the stock its 12th biggest position. P.A.W. Capital Corp’s holdings in Enovix were worth $1,087,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Fifth Third Bancorp lifted its stake in shares of Enovix by 66.7% in the 4th quarter. Fifth Third Bancorp now owns 2,500 shares of the company’s stock valued at $27,000 after purchasing an additional 1,000 shares during the period. Prospera Private Wealth LLC acquired a new position in shares of Enovix in the 3rd quarter valued at $27,000. R Squared Ltd acquired a new position in shares of Enovix in the 4th quarter valued at $64,000. Voisard Asset Management Group Inc. lifted its stake in shares of Enovix by 40.0% in the 3rd quarter. Voisard Asset Management Group Inc. now owns 7,000 shares of the company’s stock valued at $65,000 after purchasing an additional 2,000 shares during the period. Finally, Quest Partners LLC lifted its stake in shares of Enovix by 318.5% in the 3rd quarter. Quest Partners LLC now owns 8,270 shares of the company’s stock valued at $77,000 after purchasing an additional 6,294 shares during the period. 50.92% of the stock is currently owned by institutional investors and hedge funds.

Enovix Price Performance

Enovix stock opened at $10.72 on Friday. Enovix Co. has a 52-week low of $5.70 and a 52-week high of $18.68. The firm has a market capitalization of $1.91 billion, a price-to-earnings ratio of -7.39 and a beta of 1.87. The company has a fifty day simple moving average of $11.15 and a 200-day simple moving average of $10.30. The company has a quick ratio of 3.61, a current ratio of 3.77 and a debt-to-equity ratio of 0.99.

Enovix (NASDAQ:ENVXGet Free Report) last released its earnings results on Wednesday, February 19th. The company reported ($0.17) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.01. Enovix had a negative net margin of 963.17% and a negative return on equity of 96.99%. The business had revenue of $9.72 million during the quarter, compared to analyst estimates of $8.77 million. On average, equities analysts anticipate that Enovix Co. will post -1.01 EPS for the current fiscal year.

Insider Activity at Enovix

In related news, Director Betsy S. Atkins sold 75,000 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $9.73, for a total value of $729,750.00. Following the completion of the sale, the director now owns 99,497 shares of the company’s stock, valued at approximately $968,105.81. This represents a 42.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 15.70% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on ENVX shares. Cantor Fitzgerald reissued an “overweight” rating and issued a $30.00 price target on shares of Enovix in a report on Thursday. Craig Hallum cut their price target on shares of Enovix from $20.00 to $18.00 and set a “buy” rating for the company in a report on Thursday. Janney Montgomery Scott lowered shares of Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price target for the company. in a report on Thursday, October 31st. Finally, Benchmark reissued a “buy” rating and issued a $25.00 price target on shares of Enovix in a report on Wednesday, October 30th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $20.30.

View Our Latest Analysis on ENVX

Enovix Profile

(Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Featured Stories

Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Co. (NASDAQ:ENVXFree Report).

Institutional Ownership by Quarter for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.